ALS Clinical Trials in San Antonio

Showing 1-20 of 52 trials

Clinical Procedures to Support Research in ALS

NCT03489278

The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.

Amyotrophic Lateral SclerosisALS-Frontotemporal DementiaPrimary Lateral Sclerosis+1 more

University of Miami1,200 participantsStarted Feb 2018

Irvine, California, United States • Palo Alto, California, United States • San Francisco, California, United States +8 more locations

COMPLETEDPhase 1< 1 mile

A First in Human Study of ORT247 in Healthy Volunteers

NCT06769620

This is a single center, double-blinded, randomized, placebo controlled single ascending dose clinical study, with the primary purpose of evaluating the safety, tolerability, pharmacokinetics (PK), and immunohistochemistry of escalating intravenous doses of ORT247 in healthy volunteers.

Amyotrophic Lateral Sclerosis (ALS)

Orthogonal Neuroscience Inc.44 participantsStarted Jun 2022

San Antonio, Texas, United States

Active Not RecruitingPhase 274 miles

A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

NCT06643481

This is a multicenter, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early-stage ALS (within 2 years of ALS symptoms onset). The study comprises a core double-blind (DB) 40-week treatment period followed by an open label extension (OLE).

Amyotrophic Lateral Sclerosis (ALS)

Novartis Pharmaceuticals251 participantsStarted Oct 2024

La Jolla, California, United States • Loma Linda, California, United States • Los Angeles, California, United States +71 more locations

Clinical Procedures to Support Research in ALS

A First in Human Study of ORT247 in Healthy Volunteers

A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

ALS Trials in Other Cities

A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS

MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)

The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

The Myelin Disorders Biorepository Project

A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

ASSESS ALL ALS Study

PREVENT ALL ALS Study

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

Prospective Database Registry Study of Scoliosis in Children With Cerebral Palsy

Arimoclomol in Amyotropic Lateral Sclerosis

Long-Term Evaluation of BIIB067 (Tofersen)

Intermuscular Coherence as a Biomarker for ALS

Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)

Other Conditions in San Antonio